| scholarly article | Q13442814 |
| P50 | author | Holly Kramer | Q46547120 |
| P2093 | author name string | Quan Dong Nguyen | |
| Gary Curhan | |||
| Chi-Yuan Hsu | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 3273-3277 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus | |
| P478 | volume | 289 |
| Q38203370 | 'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'. |
| Q37345660 | A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8). |
| Q45972129 | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q36966926 | A pilot trial to examine the association between circulating endothelial cell levels and vascular injury in patients with diabetes and chronic kidney disease. |
| Q47294911 | A polygenic score for schizophrenia predicts glycemic control |
| Q30486667 | A story of microalbuminuria and diabetic nephropathy |
| Q37277951 | Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes |
| Q44098469 | Albuminuria in hypertension |
| Q38724392 | Antihypertensive therapy for the prevention of nephropathy in diabetic hypertensive patients. |
| Q57459125 | Appropriateness of Using Tests for Blood Glucose and Diabetic Complications in Clinical Practice: Experiences in a Hospital in Thailand |
| Q41689200 | Arterial Stiffness Is More Associated with Albuminuria than Decreased Glomerular Filtration Rate in Patients with Type 2 Diabetes Mellitus: The REBOUND Study. |
| Q33585696 | Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients |
| Q46891103 | Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes |
| Q93172593 | Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study |
| Q38290083 | Biomarkers in diabetic nephropathy: Present and future |
| Q34540591 | C-peptide and diabetic kidney disease |
| Q42104158 | Cancer risk in patients with diabetic nephropathy: A retrospective cohort study in Hong Kong |
| Q87430777 | Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study |
| Q33702434 | Cerebral microvascular disease predicts renal failure in type 2 diabetes |
| Q37364966 | Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes |
| Q38629322 | Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease |
| Q87393470 | Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus |
| Q35926064 | Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes. |
| Q38819523 | Chronic kidney disease - determinants of progression and cardiovascular risk. PROGREDIR cohort study: design and methods |
| Q34385492 | Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. |
| Q26822369 | Chronic kidney disease screening methods and its implication for Malaysia: an in depth review |
| Q52687560 | Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. |
| Q38544077 | Circulating microRNAs and diabetes: potential applications in medical practice. |
| Q39482221 | Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. |
| Q49858996 | Clinical and pathological factors associated with progression of diabetic nephropathy. |
| Q51933361 | Clinical utility of estimated glomerular filtration rates in predicting renal risk in a district diabetes population. |
| Q37273467 | Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases |
| Q47835308 | Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. |
| Q36270259 | Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. |
| Q46558815 | Comparative performance of four equations estimating glomerular filtration rate in adult Chinese diabetics |
| Q36340573 | Comparison of the Rate of Renal Function Decline in NonProteinuric Patients With and Without Diabetes. |
| Q33944806 | Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study |
| Q53497916 | Con: Biomarkers in glomerular diseases: putting the cart before the wheel? |
| Q46720646 | Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus |
| Q38939078 | Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. |
| Q59101867 | Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus |
| Q34539983 | Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes |
| Q37364907 | Cystatin C, albuminuria, and mortality among older adults with diabetes. |
| Q37305847 | Defining incident chronic kidney disease in the research setting: The ARIC Study |
| Q37330309 | Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension |
| Q42777311 | Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study. |
| Q33932739 | Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study |
| Q38709338 | Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies |
| Q28086840 | Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q34609759 | Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives |
| Q34161874 | Diabetic kidney disease: from epidemiology to clinical perspectives |
| Q90429607 | Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patient |
| Q28742785 | Diabetic nephropathy - Epidemiology in Asia and the current state of treatment |
| Q37738193 | Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center |
| Q35946123 | Diabetic nephropathy in African-American patients |
| Q61827265 | Diabetische Nephropathie – Update 2012 |
| Q39171913 | Diagnosis and Management of Type 2 Diabetic Kidney Disease |
| Q38088843 | Diagnostic biomarkers of diabetic nephropathy. |
| Q36555409 | Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease |
| Q38139836 | Differential diagnosis of glomerular disease: a systematic and inclusive approach |
| Q64264709 | Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice |
| Q30571680 | Does multimorbidity influence the occurrence rates of chronic conditions? A claims data based comparison of expected and observed prevalence rates |
| Q42580468 | Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes? |
| Q33776176 | Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials |
| Q26741494 | Early detection of diabetic kidney disease: Present limitations and future perspectives |
| Q46573006 | Early detection of diabetic nephropathy |
| Q53484082 | Effect of Home Blood Pressure on Inducing Remission/Regression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus. |
| Q35271439 | Effect of pentoxifylline on microalbuminuria in diabetic patients: a randomized controlled trial |
| Q51354839 | Effect of the best compatibility of components in Corni Fructus on WT1 expression in glomerular podocytes of type 2 diabetic rats with early nephropathy. |
| Q90518624 | Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: a retrospective cohort study |
| Q33934090 | Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis |
| Q54704417 | Elevated serum creatinine and a normal urinalysis: a short differential diagnosis in the etiology of renal failure. |
| Q50643798 | Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients. |
| Q52885585 | Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. |
| Q82636138 | Expert consensus on management of diabetic patients with impairment of renal function |
| Q35225516 | Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes |
| Q35344925 | Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study |
| Q36201450 | Foot insensitivity is associated with renal function decline in patients with type 2 diabetes: a cohort study |
| Q36249519 | Glomerular hyperfiltration and renal disease progression in type 2 diabetes |
| Q36678611 | Haptoglobin genotype and its role in diabetic cardiovascular disease |
| Q37429200 | Haptoglobin genotype and renal function decline in type 1 diabetes |
| Q43826500 | Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment |
| Q33550730 | High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data |
| Q58762435 | Histone Deacetylase Inhibitors and Diabetic Kidney Disease |
| Q26799443 | Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade |
| Q38629320 | Hypertension-attributed nephropathy: what's in a name? |
| Q37427251 | Improving microvascular outcomes in patients with diabetes through management of hypertension |
| Q34669819 | In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. |
| Q50048667 | Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria. |
| Q34704542 | Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002 |
| Q43184371 | Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD. |
| Q37531889 | Integrating albuminuria and GFR in the assessment of diabetic nephropathy |
| Q57501723 | Is chronic kidney disease associated with diabetic retinopathy in Asian adults? 在亚洲成年人中慢性肾病与糖尿病视网膜病变相关吗？ |
| Q37231183 | Joint Modeling of Covariates and Censoring Process Assuming Non-Constant Dropout Hazard |
| Q38148018 | Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency |
| Q30978708 | Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease |
| Q36925586 | Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study |
| Q36783886 | Limitations and future treatment options in type 2 diabetes with renal impairment |
| Q37320957 | Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes |
| Q54568444 | Managing chronic kidney disease in type 2 diabetes in family practice. |
| Q36602500 | Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3 |
| Q84423465 | Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors |
| Q35841146 | More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients |
| Q42253708 | Murine glomerular transcriptome links endothelial cell-specific molecule-1 deficiency with susceptibility to diabetic nephropathy. |
| Q43202927 | Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial |
| Q54295646 | New approaches for the evaluation of renal vascular function in diabetes. |
| Q29417066 | New susceptibility loci associated with kidney disease in type 1 diabetes |
| Q26786923 | Non-Proteinuric Diabetic Nephropathy |
| Q51201453 | Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. |
| Q90388274 | Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study |
| Q38241742 | Non-proteinuric diabetic nephropathy |
| Q43461389 | Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes |
| Q52887018 | Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease. |
| Q37269433 | Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). |
| Q39443166 | Normoalbuminuric diabetic kidney disease |
| Q36126281 | Normoalbuminuric diabetic kidney disease in the U.S. population |
| Q86624831 | Novel urinary biomarkers in pre-diabetic nephropathy |
| Q37278124 | Obstructive sleep apnea and diabetic nephropathy: a cohort study. |
| Q37968503 | Obstructive sleep apnea and kidney disease: is there any direct link? |
| Q35632314 | Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy |
| Q46923320 | Performance and comparison of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese Type 2 diabetic population |
| Q41611136 | Plasma and Urinary Type IV Collagen Levels for Early Detection of Nephropathy in Type 2 Diabetes Mellitus Patients |
| Q37396861 | Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study |
| Q43148852 | Postprandial hyperglycemia and hyperinsulinemia associated with renal arterio-arteriolosclerosis in chronic kidney disease. |
| Q92406599 | Presence of Carotid Plaque Is Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Normal Renal Function |
| Q33612502 | Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. |
| Q36249768 | Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). |
| Q33382616 | Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). |
| Q33770056 | Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes |
| Q36687485 | Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus |
| Q41187589 | Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre |
| Q35573627 | Prevalence of nephropathy in the German diabetes population-Is early referral to nephrological care a realistic demand today? |
| Q34582088 | Prevalence of reduced renal function among diabetic hypertensive patients. |
| Q37541414 | Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes |
| Q36657594 | Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications |
| Q36670632 | Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre |
| Q36782672 | Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease |
| Q36334589 | Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study |
| Q34887952 | Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus |
| Q93609101 | References |
| Q36662078 | Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria |
| Q54606277 | Relationship between peripheral artery disease and combined albuminuria and low estimated glomerular filtration rate among elderly patients with type 2 diabetes mellitus. |
| Q34498076 | Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease |
| Q44993831 | Relevance of chronic kidney disease and cardiovascular prognosis in arterial hypertension |
| Q26799509 | Renal Biopsy in Type 2 Diabetic Patients |
| Q35868686 | Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study |
| Q57179232 | Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition |
| Q30556744 | Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function |
| Q36329456 | Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences |
| Q35639139 | Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis |
| Q57313686 | Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care |
| Q37307169 | Risk factors for end-stage renal disease: 25-year follow-up |
| Q34699197 | Risks of rapid decline renal function in patients with type 2 diabetes |
| Q35790640 | Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus |
| Q46784474 | Significance of estimating the glomerular filtration rate for the management of hypertension in type 2 diabetes with microalbuminuria |
| Q35898292 | Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes |
| Q35153298 | Slowing nephropathy progression: focus on proteinuria reduction |
| Q33741426 | Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus. |
| Q37036416 | Standards of medical care in diabetes--2009. |
| Q33554238 | Standards of medical care in diabetes--2010. |
| Q34425055 | Standards of medical care in diabetes--2011. |
| Q24632533 | Standards of medical care in diabetes--2012 |
| Q29620309 | Standards of medical care in diabetes--2013 |
| Q34587130 | Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2. |
| Q36478002 | Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria |
| Q38857166 | Targeting inflammation in diabetic kidney disease: early clinical trials |
| Q90583191 | Temporal trends in the prevalence of albuminuria and reduced eGFR in Japanese patients with type 2 diabetes |
| Q37064114 | Temporal trends in the prevalence of diabetic kidney disease in the United States |
| Q36822302 | The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease |
| Q35239057 | The Relationship between Estimated Glomerular Filtration Rate and Diabetic Retinopathy |
| Q36877238 | The association of genetic variants of type 2 diabetes with kidney function |
| Q36883411 | The association of retinopathy and low GFR in type 2 diabetes. |
| Q37078185 | The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. |
| Q33583220 | The effects of glucose-lowering therapies on diabetic kidney disease |
| Q38174491 | The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? |
| Q42053713 | The large spectrum of renal disease in diabetic patients |
| Q52334977 | The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients-a retrospective descriptive study. |
| Q35924547 | The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study |
| Q42554498 | The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy |
| Q92889231 | The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes |
| Q35821305 | The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). |
| Q90171437 | The tubular hypothesis of nephron filtration and diabetic kidney disease |
| Q38209811 | Therapeutic approaches to diabetic nephropathy--beyond the RAS. |
| Q37449207 | Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? |
| Q46939789 | Thiazolidinediones and progression of renal disease in patients with diabetes |
| Q38492248 | Update on blood pressure control and renal outcomes in diabetes mellitus |
| Q38258271 | Updating the natural history of diabetic nephropathy |
| Q36207045 | Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus |
| Q35009712 | Urinary biomarkers for early diabetic nephropathy: beyond albuminuria |
| Q36902065 | Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes |
| Q33645242 | Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy |
| Q35043786 | Variants of GCKR affect both β-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2. |
| Q53620509 | [Diabetic kidney disease - Update 2016]. |
| Q54253584 | miRNA profiling for the early detection and clinical monitoring of diabetic kidney disease. |
Search more.